News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
711,187 Results
Type
Article (41853)
Company Profile (261)
Press Release (669073)
Multimedia
Podcasts (53)
Webinars (12)
Section
Business (207377)
Career Advice (2112)
Deals (35719)
Drug Delivery (100)
Drug Development (82162)
Employer Resources (176)
FDA (16346)
Job Trends (15119)
News (350274)
Policy (33107)
Tag
Academia (2681)
Accelerated approval (5)
Adcomms (21)
Allergies (85)
Alliances (50383)
ALS (91)
Alzheimer's disease (1414)
Antibody-drug conjugate (ADC) (125)
Approvals (16347)
Artificial intelligence (267)
Autoimmune disease (21)
Automation (16)
Bankruptcy (365)
Best Places to Work (11775)
BIOSECURE Act (20)
Biosimilars (107)
Biotechnology (182)
Bladder cancer (79)
Brain cancer (28)
Breast cancer (281)
Cancer (2291)
Cardiovascular disease (181)
Career advice (1771)
Career pathing (31)
CAR-T (156)
Cell therapy (435)
Cervical cancer (19)
Clinical research (66741)
Collaboration (848)
Compensation (533)
Complete response letters (20)
COVID-19 (2669)
CRISPR (44)
C-suite (252)
Cystic fibrosis (104)
Data (2225)
Decentralized trials (2)
Denatured (18)
Depression (46)
Diabetes (274)
Diagnostics (6485)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (124)
Drug pricing (104)
Drug shortages (25)
Duchenne muscular dystrophy (97)
Earnings (87079)
Editorial (38)
Employer branding (22)
Employer resources (150)
Events (114425)
Executive appointments (736)
FDA (17620)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (772)
Gene editing (108)
Generative AI (23)
Gene therapy (318)
GLP-1 (733)
Government (4512)
Grass and pollen (4)
Guidances (67)
Healthcare (19151)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (117)
Indications (29)
Infectious disease (2816)
Inflammatory bowel disease (141)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (97)
Interviews (334)
IPO (16608)
IRA (41)
Job creations (3762)
Job search strategy (1496)
Kidney cancer (11)
Labor market (38)
Layoffs (481)
Leadership (20)
Legal (8073)
Liver cancer (77)
Lung cancer (322)
Lymphoma (155)
Machine learning (7)
Management (59)
Manufacturing (309)
MASH (68)
Medical device (13528)
Medtech (13533)
Mergers & acquisitions (19661)
Metabolic disorders (701)
Multiple sclerosis (81)
NASH (17)
Neurodegenerative disease (94)
Neuropsychiatric disorders (27)
Neuroscience (1963)
NextGen: Class of 2025 (6631)
Non-profit (4640)
Now hiring (39)
Obesity (374)
Opinion (222)
Ovarian cancer (75)
Pain (90)
Pancreatic cancer (84)
Parkinson's disease (151)
Partnered (21)
Patents (235)
Patient recruitment (115)
Peanut (46)
People (58789)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20799)
Phase II (29380)
Phase III (21883)
Pipeline (1212)
Policy (143)
Postmarket research (2606)
Preclinical (8924)
Press Release (67)
Prostate cancer (106)
Psychedelics (33)
Radiopharmaceuticals (248)
Rare diseases (389)
Real estate (6037)
Recruiting (67)
Regulatory (22624)
Reports (46)
Research institute (2427)
Resumes & cover letters (363)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (69)
Series A (136)
Series B (86)
Service/supplier (11)
Sickle cell disease (53)
Special edition (14)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3690)
State (2)
Stomach cancer (13)
Supply chain (69)
Tariffs (41)
The Weekly (33)
Vaccines (709)
Venture capitalists (41)
Weight loss (243)
Women's health (35)
Worklife (16)
Date
Today (203)
Last 7 days (911)
Last 30 days (2667)
Last 365 days (33230)
2025 (10847)
2024 (35731)
2023 (40578)
2022 (51749)
2021 (56336)
2020 (54727)
2019 (47389)
2018 (35733)
2017 (32791)
2016 (32289)
2015 (38339)
2014 (31993)
2013 (27047)
2012 (29169)
2011 (29828)
2010 (27926)
Location
Africa (754)
Alabama (54)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (38689)
Australia (6370)
California (6164)
Canada (2027)
China (527)
Colorado (268)
Connecticut (280)
Delaware (148)
Europe (84409)
Florida (916)
Georgia (210)
Idaho (57)
Illinois (546)
India (26)
Indiana (309)
Iowa (11)
Japan (166)
Kansas (105)
Kentucky (24)
Louisiana (11)
Maine (70)
Maryland (905)
Massachusetts (4644)
Michigan (221)
Minnesota (399)
Mississippi (2)
Missouri (82)
Montana (28)
Nebraska (25)
Nevada (63)
New Hampshire (65)
New Jersey (1736)
New Mexico (30)
New York (1763)
North Carolina (996)
North Dakota (9)
Northern California (2694)
Ohio (206)
Oklahoma (14)
Oregon (37)
Pennsylvania (1387)
Puerto Rico (13)
Rhode Island (34)
South America (1137)
South Carolina (23)
South Dakota (1)
Southern California (2313)
Tennessee (104)
Texas (912)
United States (23381)
Utah (183)
Virginia (148)
Washington D.C. (62)
Washington State (557)
West Virginia (3)
Wisconsin (55)
711,187 Results for "reflect scientific inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Reflect Scientific Inc. Reports Strong Revenue Growth in 2024
March 20, 2025
·
3 min read
Reflect Scientific Inc Secures $550,000 Sale with Major BioPharma Company
Reflect Scientific, Inc. is pleased to announce a significant sale of its cutting-edge freezer systems to a major biopharmaceutical company.
April 30, 2024
·
3 min read
BioMidwest
Reflect Scientific Inc. Addresses Rescheduled Freezer Shipment for a $40B BioPharma Company
Reflect Scientific, Inc., a leader in the development of ultra-low temperature storage solutions, provided an update on the previously announced landmark order from a premier BioPharma company, valued at over $500,000.
February 7, 2024
·
2 min read
Press Releases
Record first-quarter revenue of €239 million, reflecting 14% topline growth
April 10, 2025
·
2 min read
Press Releases
Immunic, Inc. to Participate in Scientific and Industry Conferences in April
April 1, 2025
·
5 min read
BioMidwest
Reflect Scientific Inc. Announces Record-Breaking Freezer Order from a $40B BioPharma Company
Reflect Scientific, Inc., a pioneering manufacturer in ultra-low temperature storage solutions, is thrilled to announce its most significant single order ever, valued at over $500,000.
September 20, 2023
·
2 min read
Business
Reflect Scientific Inc Reports First Quarter 2023 Results
Reflect Scientific, Inc., a provider of diverse products and services for the biotechnology, pharmaceutical, and transportation industries reported financial results for the first quarter ended March 31, 2023.
May 12, 2023
·
3 min read
BioMidwest
Reflect Scientific Inc Receives Order for B-90 Plasma Freezer, Continues to Expand Clientele
Reflect Scientific, Inc., a leading provider of innovative cold storage solutions, is pleased to announce the receipt of a significant order for their state-of-the-art B-90 plasma freezer.
June 28, 2023
·
3 min read
BioMidwest
Reflect Scientific Inc Announces Year-End Financial Results for 2022
Reflect Scientific Inc, a provider of ultra-low temperature freezers and chillers for the biotech, pharmaceutical, and cannabis industries, announced its financial results for the year ended December 31, 2022.
March 31, 2023
·
5 min read
Podcasts
COVID Reflections, Novo’s Next-Gen Weight Loss Struggles, Another Depression Miss, More
BioSpace
remembers COVID-19 five years after the pandemic was declared, Novo Nordisk’s CagriSema again misses expectations as the company joins a lawsuit filed by drug compounders against the FDA, Viking secures ample supply of its investigational obesity medication, J&J strikes out in depression, and Makary and Bhattacharya near confirmation.
March 12, 2025
·
1 min read
·
Heather McKenzie
1 of 71,119
Next